ArticlePLoS pathogens2025
A comprehensive PDCoV-host proteome interaction map reveals potential antiviral targets.
Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deciphering host-virus interaction networks in ALV infection: an integrative multi-omics perspective.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Porcine deltacoronavirus (PDCoV), an enteric member of the coronavirus family, has emerged globally over the past decade, causing significant impacts on the swine industry. While studies of virus-host protein interactions provide crucial insights into viral engagement with host cells during infection, research specifically targeting PDCoV-host interaction factors remains limited. To identify host proteins involved in PDCoV replication, comprehensive identification of RNA-binding proteins by mass spectrometry (ChIRP-MS) was employed to identify host proteins interacting with the PDCoV genomic RNA. Concurrently, affinity purification mass spectrometry (AP-MS) was utilized to identify host interactors of PDCoV-encoded proteins. A total of 671 host proteins were identified in our analysis. These host interactors participate in diverse cellular processes, including extensive representation of metabolic enzymes, transcription factors, RNA-binding proteins (RBPs), and intracellular signal transduction components. Construction of a comprehensive PDCoV-host protein interaction network map revealed that SYNCRIP (heterogeneous nuclear ribonucleoprotein Q, hnRNP Q), functions as a novel host restriction factor with PDCoV. SYNCRIP interacts with the N proteins of multiple coronaviruses and competitively displaces HUWE1 to bind the PDCoV N protein, thereby blocking its ubiquitin-proteasome-mediated degradation. Furthermore, Isoforsythiaside, a small-molecule inhibitor designed to target SYNCRIP, demonstrated substantial antiviral potential both in vitro and in vivo. In summary, this study provides a comprehensive catalog of functional PDCoV viral RNA (vRNA)/viral Protein (vProtein)-host protein interactions. This resource not only informs the understanding of pan-coronavirus infection mechanisms but also nominates host cellular processes as potential targets for antiviral intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.